Science· 2015Q1

Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

Naiyer A. Rizvi, Matthew D. Hellmann, Alexandra Snyder, Pia Kvistborg et al.

Short summary

Higher tumor mutation burden, a molecular smoking signature, and neoantigen burden predict response to PD-1 blockade in non-small cell lung cancer.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

OncologyMedicine